4Biology is a focused search engine built for biology students, researchers, educators, and lab managers. We combine multiple indexes, curated sources, and AI tools to surface publications, protocols, datasets, suppliers, and learning resources that matter to life scientists. Use the site to save time, find specialized resources, and get context-specific search results not optimized for general web traffic. Part of the 4SEARCH network of topic specific search engines.
(NASDAQ:TARS) Seeking Alpha - Tarsus Pharmaceuticals is well-positioned with Xdemvy's rapid commercial ramp and robust $2B peak sales potential. - Recent acquisitions of IRX-101 and ALK-101 diversify the pipeline, adding both low-risk and high-reward late-stage assets. - IRX-101's clinical data and market…
A column by Winona LaDuke, an Ojibwe writer and economist on Minnesota’s White Earth Reservation. She also is co-curator of the Giiwedinong Museum in Park Rapids, Minnesota. LaDuke: Remember the imago cells, and vote for change A column by Winona…
Scientists have captured rare 4K footage of a deep-sea fish with a transparent head and unusual green eyes in the Pacific Ocean. Known as the barreleye fish, the rarely spotted marine creature was filmed by researchers from the Monterey Bay Aquarium…
Pam Belluck is a seasoned health and science journalist whose work explores the impact of medicine, policy, and innovation on individuals and society. She has reported extensively on topics like reproductive health, long-term illness, brain science, and public health, with…
AdVantageNews.com (Top row, left to right) Rob Schmidt, Miriam Bell, Debbie Barron, Rhonda Webel, Julie Repp, Michelle Domer, David Cobb, Justin Dixon, Phil Roggio(Bottom row, left to right) Summer Moore, Penny Brown, SJ Morrison, Susan Thomas, Amanda Smith,…
Shanghai Junshi Biosciences (SEHK:1877) reported first patient dosing in a new phase 3 trial of JS207/JS007 for advanced hepatocellular carcinoma. The company also began dosing in a separate phase 3 study of JS203 targeting relapsed or refractory diffuse large B cell lymphoma. Junshi Biosciences…
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial. In adults aged 50 years and older, all 28 serotypes shared with PCV20 and/or PCV21 met the noninferiority criterion, and all 4 unique and cross-reactive serotypes met the superiority criterion.
Colorado agriculture officials have confirmed the state’s first bird flu case in dairy cattle since 2024 in Weld County after a routine test of a bulk milk tank came back positive for the virus, state leaders said Friday. More tests from…
Oct 27, 2026, 16:00 ET New Long-Term UPLIZNA Data in IgG4-Related Disease and Real-World Evidence for KRYSTEXXA and TAVNEOS Further Highlight Amgen's Broad Portfolio and Commitment to People Living with Rare Diseases THOUSAND OAKS, Calif., Oct. 27, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced plans…
New hybrids bred from flowers native to South Africa and by UH Mānoa researchers will reduce the state's reliance on imports. University of Hawaiʻi at Mānoa researchers have successfully bred new “tropical” pincushion protea hybrids that will reduce reliance on…